Anti-NaPi2b/SLC34A2 Antibody (Lifastuzumab)
Catalog No.
F1444
Anti-NaPi2b/SLC34A2 Antibody (Lifastuzumab)
Featured Products
Lifastuzumab is a humanizedNaPi2bMonoclonal antibody (IgG1 type). Lifastuzumab can be usedADC Linker With monomethylauristatin E (MMAE) coupling to form the antibody-drug conjugate (ADC) Lifastuzumab vedotin (DNIB0600A) with anti-cancer activity.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.66 kDa
Dry ice
1615697-16-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Lifastuzumab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
O95436
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Human NaPi2b HEK293 Cell Line were stained with Anti-NaPi2b / SLC34A2 Reference Antibody (lifastuzumab)and negative control protein respectively, washed and then followed by PE and analyzed with FACS, The EC50 is 1.585 ug/mL.
NaPi2b / SLC34A2
Please avoid freeze-thaw cycles.